Complement Therapeutics operates as a preclinical stage company.
Complement Therapeutics has raised $78.7M in total funding. The most recent round was Series A. The last funding was announced in April 2023.
Complement Therapeutics's investors include Cambridge Innovation Capital, Forbion Capital Partners, BioGeneration Ventures, Panakes Partners, Hadean Ventures.
Complement Therapeutics is headquartered in London, United Kingdom.
Complement Therapeutics operates as a preclinical stage company.
Complement Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Complement Therapeutics — Funding & Investors." VCBacked, April 17, 2023, https://www.vcbacked.co/company/complement-therapeutics. Accessed November 13, 2026.
VCBacked. (2023). Complement Therapeutics — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/complement-therapeutics
{{cite web |title=Complement Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/complement-therapeutics |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Complement Therapeutics? Request a listing update